Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of combination of co-cultured CIK cells and TABP-EIC-WTN cells in treatment of prostatic cancer

A prostate cancer, co-cultivation technology, applied in the field of biomedicine, can solve the problems of inability to construct, low efficiency, low specific binding efficiency, etc., and achieves good application prospects, overcoming technical defects, and good therapeutic effects.

Pending Publication Date: 2022-04-12
CHENGNUO REGENERATIVE MEDICINE TECH (ZHUHAI HENGQIN NEW AREA) CO LTD
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the main technical problems in this field include: Although tumor immunotherapy has made some progress, there are still problems such as low efficiency; Chimeric antigen receptor immune cell therapy relies on specific tumor-associated antigens for specific tumor types , if the tumor-associated antigen of the tumor is unclear or unidentified, it is impossible to prepare a relevant specific recognition single-chain antibody sequence based on the tumor-associated antigen, and then it is impossible to construct a specific CAR that can effectively recognize tumor cells, and CAR-T or CAR-NK cells that specifically recognize and kill tumor cells; the preparation cycle of antibodies is long and the specific binding efficiency is generally low

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of combination of co-cultured CIK cells and TABP-EIC-WTN cells in treatment of prostatic cancer
  • Application of combination of co-cultured CIK cells and TABP-EIC-WTN cells in treatment of prostatic cancer
  • Application of combination of co-cultured CIK cells and TABP-EIC-WTN cells in treatment of prostatic cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0139] Example 2 Verification of WTN polypeptide specificity

[0140] 1. Experimental method

[0141] The WTN polypeptide was detected by immunofluorescence with the Lncap cell line with higher PSMA expression level and the PC3 cell line with lower PSMA expression level, and the fluorescent marker used was FITC (i.e. FITC-labeled WTN polypeptide).

[0142] 2. Experimental results

[0143] Fluorescence detection of WTN polypeptide and Lncap cell line such as figure 1 As shown, the fluorescence detection of WTN polypeptide and PC3 cell line is as follows figure 2 shown; figure 1 The center of the dot is the nucleus, and the light color around the dot is the fluorescence displayed by the combination of WTN and the cell surface antigen PSMA; figure 2 Only the nuclei were stained, and it can be seen that the cell surface fluorescence marked by WTN was only in figure 1 Appeared in , proving that the combination of WTN and cell surface antigen PSMA has high specificity.

Embodiment 3

[0144] Embodiment 3 The cell line involved in the present invention, its culture method, construction method

[0145] 1. Construction method of TABP-EIC-WTN

[0146] (1) Preparation of TABP-EIC-WTN cells

[0147] The NK cells used in the experiments involved in this patent are obtained from the expansion of peripheral blood mononuclear cells (PBMC).

[0148] (2) Construction of tumor antigen-binding peptide expression vector

[0149] The tumor antigen binding peptide structure (the complete structure is: WTN polypeptide region-CD8α hinge region-2B4 transmembrane domain-2B4 co-stimulatory domain-NKG2D primary signal transduction domain, the nucleic acid sequence is shown in SEQ ID NO:12) sequence Obtained for gene synthesis (General Biology), the expression vector is pLenti-EF1a-Backbone(NN) (addgene #27961). The tumor antigen-binding peptide structure is inserted into the enzyme cutting sites BsiWI and EcoRI (that is, the sequence shown in SEQ ID NO: 12 is replaced with the...

Embodiment 4

[0163] Example 4 Upregulation of PD-L1 expression on C4-2 cells co-cultured with TABP-EIC-WTN cells depends on IFN-γ

[0164] C4-2 GFP cells were co-cultured with TABP-EIC-WTN cells, and flow cytometry was performed at 2, 6, 12, and 24 hours, and the results were as follows image 3 Shown: And detect the PD-L1 expressed in C4-2 cells, the results are as follows image 3 Shown: The mean fluorescence intensity (MFI) of PD-L1 in C4-2 cells and the percentage of C4-2 cells expressing PD-L1 were significantly up-regulated over time.

[0165] TABP-EIC-WTN cells were cultured, and in the presence or absence of C4-2 GFP co-cultivation, the IFN-γ secretion level in the medium supernatant was measured by ELISA at the time points of 2, 6, 12, and 24 hours, The result is as Figure 4 shown.

[0166] Add IFN-γ to C4-2 cells, and the expression of PD-L1 on C4-2 cells under different concentrations of IFN-γ, the results are as follows Figure 5 Shown: The mean fluorescence intensity (MFI...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of co-cultured CIK cells and TABP-EIC-WTN cells in treatment of prostatic cancer, the TABP-EIC-WTN cells are tumor antigen binding peptide-engineered immune cells obtained by connecting one or more WTN polypeptides obtained by screening in series through a linker to serve as an antigen recognition area, and experimental verification shows that the TABP-EIC-WTN cells have the advantages that the CIK cells and the TABP-EIC-WTN cells are combined to form the tumor antigen binding peptide-engineered immune cells; the combination of the co-cultured CIK cells and the TABP-EIC-WTN cells has a good treatment effect on the prostatic cancer, and a new effective treatment method is provided for the treatment of the prostatic cancer.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, in particular, the invention relates to the combination of co-cultured CIK cells and TABP-EIC-WTN cells in the treatment of prostate cancer. Background technique [0002] At present, tumor has become the second leading cause of death after cardiovascular disease in the world, and the number of patients is also increasing year by year. The current methods of tumor treatment mainly include surgery, radiotherapy, chemotherapy and targeted drug therapy, etc. However, these traditional tumor treatment methods have certain limitations. Different from traditional tumor treatment methods, tumor immunotherapy does not directly act on the lesion, but fights against tumors by regulating the body's immune defense mechanism. In recent years, the emergence of new targets and new technologies for tumor immunotherapy also reflects the unlimited potential of tumor immunotherapy. Tumor immunotherapy refers to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C12N15/11C07K19/00A61K39/00A61P35/00G01N33/574
CPCC07K7/08C07K14/7051A61K39/001195A61P35/00G01N33/57434G01N33/57492C07K2319/03C07K2319/33
Inventor 尹乐顾雨春
Owner CHENGNUO REGENERATIVE MEDICINE TECH (ZHUHAI HENGQIN NEW AREA) CO LTD